AU699199B2 - The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (HP) associated syndromes and infectious diseases - Google Patents
The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (HP) associated syndromes and infectious diseasesInfo
- Publication number
- AU699199B2 AU699199B2 AU20713/95A AU2071395A AU699199B2 AU 699199 B2 AU699199 B2 AU 699199B2 AU 20713/95 A AU20713/95 A AU 20713/95A AU 2071395 A AU2071395 A AU 2071395A AU 699199 B2 AU699199 B2 AU 699199B2
- Authority
- AU
- Australia
- Prior art keywords
- therapy
- dimeticone
- helicobacter pylori
- prevention
- infectious diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4409357A DE4409357C2 (de) | 1994-03-18 | 1994-03-18 | Verwendung von Dimeticon zur Eradikation von Heliobacter pylori |
| DEP4409357 | 1994-03-18 | ||
| PCT/EP1995/000972 WO1995025525A1 (en) | 1994-03-18 | 1995-03-15 | The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2071395A AU2071395A (en) | 1995-10-09 |
| AU699199B2 true AU699199B2 (en) | 1998-11-26 |
Family
ID=6513210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU20713/95A Ceased AU699199B2 (en) | 1994-03-18 | 1995-03-15 | The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (HP) associated syndromes and infectious diseases |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0804242A1 (de) |
| JP (1) | JPH09510466A (de) |
| CN (1) | CN1244129A (de) |
| AU (1) | AU699199B2 (de) |
| CA (1) | CA2185882A1 (de) |
| CZ (1) | CZ300796A3 (de) |
| DE (1) | DE4409357C2 (de) |
| FI (1) | FI963682L (de) |
| HU (1) | HU215595B (de) |
| NO (1) | NO963893L (de) |
| NZ (1) | NZ282805A (de) |
| PL (1) | PL316307A1 (de) |
| SK (1) | SK132496A3 (de) |
| WO (1) | WO1995025545A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6100245A (en) * | 1999-09-07 | 2000-08-08 | Mcneil-Ppc, Inc. | Use of simethicone to treat ulcerative colitis |
| US7648711B2 (en) * | 2003-05-25 | 2010-01-19 | Yuwan Wang | Dimethicone-containing sustained release injection formulation |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120533A (en) * | 1989-01-19 | 1992-06-09 | Steigerwald Arzneimittelwerk Gmbh | Treatment of ulcers of the gastrointestinal tract using dimethylpolysiloxane |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3848M (fr) * | 1964-05-04 | 1966-01-17 | Robert Schapiro | Associations thérapeutiques pour traitement de nombreux troubles digestifs organiques ou fonctionnels. |
| GB1357737A (en) * | 1970-10-09 | 1974-06-26 | Arpic Sa | Sustained release pharmaceutical compositions |
| NZ217844A (en) * | 1985-10-11 | 1989-10-27 | Sumitomo Pharma | A sustained release pharmaceutical composition containing silicone elastomer and an albumin |
| US4837029A (en) * | 1987-04-06 | 1989-06-06 | Carolina Medical Products, Inc. | Low foaming, aqueously homogenizable rifampin composition |
| US5446070A (en) * | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| IE903302A1 (en) * | 1989-09-15 | 1991-04-10 | Pehrom Pharmaceutical Corp | Topical preparation for treatment of aphthous ulcers and¹other lesions |
| NZ235876A (en) * | 1989-11-01 | 1992-06-25 | Mcneil Ppc Inc | Pharmaceutical compositions containing effective amount of antidiarrheal composition and antiflatulent effective amount of simethicone |
| US5229137A (en) * | 1992-05-06 | 1993-07-20 | Brigham And Women's Hospital, Inc. | Methods and pharmaceutical compositions for treating episodic heartburn |
| AU4682193A (en) * | 1992-07-29 | 1994-03-03 | Merck & Co., Inc. | Dexibuprofen/antacid/simethicone combinations |
-
1994
- 1994-03-18 DE DE4409357A patent/DE4409357C2/de not_active Expired - Fee Related
-
1995
- 1995-03-15 FI FI963682A patent/FI963682L/fi unknown
- 1995-03-15 CZ CZ963007A patent/CZ300796A3/cs unknown
- 1995-03-15 WO PCT/EP1995/000973 patent/WO1995025545A1/en not_active Ceased
- 1995-03-15 EP EP95913130A patent/EP0804242A1/de not_active Withdrawn
- 1995-03-15 JP JP7524363A patent/JPH09510466A/ja not_active Withdrawn
- 1995-03-15 PL PL95316307A patent/PL316307A1/xx unknown
- 1995-03-15 SK SK1324-96A patent/SK132496A3/sk unknown
- 1995-03-15 CN CN95192553A patent/CN1244129A/zh active Pending
- 1995-03-15 HU HU9602839A patent/HU215595B/hu not_active IP Right Cessation
- 1995-03-15 AU AU20713/95A patent/AU699199B2/en not_active Ceased
- 1995-03-15 NZ NZ282805A patent/NZ282805A/en not_active IP Right Cessation
- 1995-03-15 CA CA002185882A patent/CA2185882A1/en not_active Abandoned
-
1996
- 1996-09-17 NO NO963893A patent/NO963893L/no not_active Application Discontinuation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120533A (en) * | 1989-01-19 | 1992-06-09 | Steigerwald Arzneimittelwerk Gmbh | Treatment of ulcers of the gastrointestinal tract using dimethylpolysiloxane |
Also Published As
| Publication number | Publication date |
|---|---|
| PL316307A1 (en) | 1997-01-06 |
| FI963682A7 (fi) | 1996-11-13 |
| FI963682L (fi) | 1996-11-13 |
| FI963682A0 (fi) | 1996-09-17 |
| HUT75711A (en) | 1997-05-28 |
| NO963893L (no) | 1996-11-04 |
| CN1244129A (zh) | 2000-02-09 |
| DE4409357C2 (de) | 1996-10-17 |
| JPH09510466A (ja) | 1997-10-21 |
| NO963893D0 (no) | 1996-09-17 |
| EP0804242A1 (de) | 1997-11-05 |
| WO1995025545A1 (en) | 1995-09-28 |
| NZ282805A (en) | 1998-02-26 |
| CA2185882A1 (en) | 1995-09-28 |
| HU215595B (hu) | 1999-01-28 |
| DE4409357A1 (de) | 1995-09-21 |
| AU2071395A (en) | 1995-10-09 |
| HU9602839D0 (en) | 1996-12-30 |
| SK132496A3 (en) | 1997-06-04 |
| CZ300796A3 (en) | 1997-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5538729A (en) | Oral treatment of helicobacter infection | |
| Marshall | Helicobacter pylori: the etiologic agent for peptic ulcer | |
| Axon | Helicobacter pylori infection | |
| RU2227033C2 (ru) | Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита | |
| WO1995025525A1 (en) | The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases | |
| Axon | Eradication of Helicobacter pylori | |
| Palmer | Gastrointestinal diseases of foals | |
| AU699199B2 (en) | The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (HP) associated syndromes and infectious diseases | |
| US6028062A (en) | Use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (Hp) associated syndromes and infectious diseases | |
| Gupta et al. | Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study. | |
| US5618564A (en) | Composition for the treatment of helicobacter pylori infection | |
| US4959384A (en) | Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders | |
| US5229380A (en) | Method for treating helicobacter pylori gastritis | |
| Spadaccini et al. | Omeprazole versus ranitidine: short‐term triple‐therapy in patients with Helicobacter pylori‐positive duodenal ulcers | |
| RU2150271C1 (ru) | Способ лечения хронического гастрита, язвенной болезни желудка и двенадцатиперстной кишки | |
| Ndidi | Gastric Ulcers; Causes, Symptoms, Treatment, and Prevention | |
| Fukuda | Suppression of Helicobacter pylori colonization with omeprazole | |
| Tzivras et al. | One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicatesHelicobacter pyloriequally and heals duodenal ulcer | |
| AU675938C (en) | Oral treatment of helicobacter infection | |
| KR970020114A (ko) | 찹쌀추출물을 함유하는 항궤양제 및 궤양 예방을 위한 음료 | |
| RU95101369A (ru) | Противоязвенное средство | |
| Itoh | Bacteriology and pathogenicity of Helicobacter pylori | |
| JP2001031576A (ja) | ヘリコバクター・ピロリの定着阻害剤 | |
| Hornick | Campylobacter pylori--a bacterial cause of peptic ulcer disease | |
| Cronin | Enteropathogenic Escherichia Coli (EPEC) in Infants' and Travelers' Diarrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |